Individualized Telemedical Assistance for Lifestyle Modification in the Treatment of Obesity and Cardiometabolic Risk Prevention (PREDIRCAM 2)
Intensificación y monitorización telemática Personalizada de la modificación Del Estilo de Vida en el Tratamiento de la Obesidad y la prevención Del Riesgo cardiometabólico
Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Listed as NCT01919372, this NA trial focuses on Obesity Type I and II and remains completed. Sponsored by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, it has been updated 8 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Oct 2021 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Oct 2021 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
▶ Show 3 earlier versions
-
May 2018 — Jun 2018 [monthly]
Completed NA
-
Mar 2018 — May 2018 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Jan 2017 — Mar 2018 [monthly]
Unknown Status NA
First recorded
Oct 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- Grupo de Bioingenieria y Telemedicina -ETSI Telecomunicacion. Universidad Politecnica de Madrid
- Spanish Clinical Research Network - SCReN
For direct contact, visit the study record on ClinicalTrials.gov .